Amarantus Forms Subsidiaries "Elto Pharma" to Focus on CNS Disorders and "MANF Therapeutics" to Focus on Ophthalmology

SAN FRANCISCO, April 17, 2017 /PRNewswire/ — Eltoprazine has successfully completed proof-of-concept Phase 2 human clinical studies in Adult ADHD, Alzheimer’s Aggression and Parkinson’s LID  Elto Pha…Read More »

Amarantus Provides Update on Restructuring Efforts and Letter of Intent with SeD Biomedical, Inc.

SAN FRANCISCO, April 5, 2017 /PRNewswire/ — INTRODUCTION On February 27, 2017, Amarantus BioScience Holdings, Inc. (OTCPK: AMBS) (“Amarantus”), a US-headquartered biotechnology company focused on dev…Read More »

Amarantus Enters into a Letter of Intent to Acquire Certain Biotechnology Assets from SeD BioMedical Inc.

SINGAPORE and SAN FRANCISCO, February 27, 2017 /PRNewswire/ — Amarantus evaluating four SeD BioMedical assets for potential acquisition into its portfolio of biotechnology assets  LOI contemplates ca…Read More »

Amarantus Announces Passing of Biotechnology Legend Dr. Joseph Rubinfeld

SAN FRANCISCO, February 10, 2017 /PRNewswire/ — Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orph…Read More »

Amarantus Announces Publication of Human Clinical Data for Engineered Skin Substitute in the Treatment of Life-Threatening Pediatric Severe Burns

ESS reduces mortality and repeated donor skin harvesting in children SAN FRANCISCO, August 8, 2016 /PRNewswire/ — Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on…Read More »

Forward Looking Statements

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements." These forward-looking statements generally are identified by the words believes," project," expects," anticipates," estimates," intends," strategy," plan," may," will," would," will be," will continue," will likely result," and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements.

This Blog is official and sanctioned by Amarantus BioScience | See Disclaimer | See Privacy Policy

Get Amarantus BioScience Blog Post Alerts